Valkyrie Pharmaceutical Boldenone 250 is presented in a 10-milliliter multidose vial and reportedly contains 250 milligrams of boldenone undecylenate per milliliter according to the label and/or packaging. Samples of this product were purchased from a European-based internet source between the dates of July 15, 2016 and August 30, 2016.
The samples were forwarded and received by the analytical laboratory SIMEC AG on August 30, 2016. SIMEC performed HPLC-UV quantitative dosage testing, ‘total aerobial microbiological count’ (TAMC) testing and ‘total yeast and mold count’ (TYMC) testing. The report was completed on Octobere 31, 2016.
The product was identified with an expiration date of July 2018.
Label claim: Valkyrie Pharmaceutical Boldenone 250 has a label claim of 250 mg/ml boldenone undecylenate.
Actual content: Valkyrie Pharmaceutical Boldenone 250 was determined to have an actual content of 236.6 mg/ml boldenone undecylenate.
No microbiological contamination was detected.
(The following images are photographs of the actual product that was submitted for testing.)
Does Valkyrie Pharmaceutical Boldenone 250 really contain 250 mg/ml of boldenone undecylenate? Is the product free of microbiological contamination? HPLC-UV, TAMC, TYMC (October 31, 2016) ...
|Last Updated||November 3, 2016|